---
search:
  boost: .9
---

# Respiratory Agents: Inhaled Agents

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EZgl36O0IDVNmjOaLaMxZ4ABmMvsDTXerkRZ61Qa7KZlcw?e=E4RanR){:target="_blank" rel="noopener}

## Criteria { data-search-exclude }

|||
| :--- | :--- |
|  Criteria 1  | 	Non-Preferred Glucocorticoids: Aerospan HFA, Alvesco, Armonair Digihaler, Armonair Respiclick, Arnuity Ellipta, Asmanex HFA, Qvar (QL), Fluticasone HFA </br> Preferred Agents: Asmanex Twisthaler, Flovent, Pulmicort Flexhaler |
| Criteria 2 |  	Non-Preferred SABAs: Levalbuterol Nebulizer Sol, Proair Digihaler, Proair Respiclick, Xopenex HFA </br> Preferred Agents: Albuterol Nebulizer Soln, Albuterol HFA, Proair HFA, Proventil HFA, Ventolin HFA |
| Criteria 3  | 	Non-Preferred ICS with LABAs: Airduo Digihaler, Airduo Respiclick, Breo Ellipta (BvG), Budesonide/Formoterol* (QL, Symbicort is BvG), Fluticasone/Salmeterol* (Advair Diskus and Advair HFA are BvG), Wixela Inhub </br> Preferred Agents: Advair Diskus, Advair HFA, Dulera, Symbicort | 
| Criteria 4   	|Non-Preferred Anticholinergics: Lonhala Magnair, Tudorza, Yupelri </br> Preferred: Atrovent HFA, Combivent Respimat, Incruse Ellipta, Ipratropium, Ipratropium/Albuterol Nebulizer Sol, Spiriva |
| Criteria 5 |  	Non-Preferred LABAs: Arformoterol, Formoterol Fumarate Nebulizer Sol </br> Preferred: Serevent Diskus, Striverdi Respimat |
|Criteria 6 |	Non-Preferred ACH/LABA: Bevespi Aerosphere, Duaklir Pressair </br> Preferred Agents: Anoro Ellipta, Stiolto |
| Criteria 7	|Non-Preferred ACH/ICS/LABA: Breztri Aerosphere, Trelegy Ellipta|
|Criteria 8	|Albuterol Nebulizer Sol 0.021% (0.63mg/3mL), 0.042% (1.25mg/3mL)- P, AR|
|Criteria 9|	Budesonide Nebulizer Sol – P, AR|

## Non-Preferred Glucocorticoids

<table>
<thead>
<tr class="header">
<th>Criteria 1   </th>
<th><p>Non-Preferred Glucocorticoids: Aerospan HFA, Alvesco, Armonair Digihaler, Armonair Respiclick, Arnuity Ellipta, Asmanex HFA, Qvar (QL), Fluticasone HFA</p>
<p>Preferred Agents: Asmanex Twisthaler, Flovent, Pulmicort Flexhaler</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Criteria 2   </td>
<td><p>Non-Preferred SABAs: Levalbuterol Nebulizer Sol, Proair Digihaler, Proair Respiclick, Xopenex HFA</p>
<p>Preferred Agents: Albuterol Nebulizer Soln, Albuterol HFA, Proair HFA, Proventil HFA, Ventolin HFA</p></td>
</tr>
<tr class="even">
<td>Criteria 3   </td>
<td><p>Non-Preferred ICS with LABAs: Airduo Digihaler, Airduo Respiclick, Breo Ellipta (BvG), Budesonide/Formoterol* (QL, Symbicort is BvG), Fluticasone/Salmeterol* (Advair Diskus and Advair HFA are BvG), Wixela Inhub</p>
<p>Preferred agents: Advair Diskus, Advair HFA, Dulera, Symbicort</p></td>
</tr>
<tr class="odd">
<td>Criteria 4   </td>
<td><p>Non-Preferred Anticholinergics: Lonhala Magnair, Tudorza, Yupelri</p>
<p>Preferred: Atrovent HFA, Combivent Respimat, Incruse Ellipta, Ipratropium, Ipratropium/Albuterol Nebulizer Sol, Spiriva</p></td>
</tr>
<tr class="even">
<td>Criteria 5   </td>
<td><p>Non-Preferred LABAs: Arformoterol, Formoterol Fumarate Nebulizer Sol</p>
<p>Preferred: Serevent Diskus, Striverdi Respimat</p></td>
</tr>
<tr class="odd">
<td>Criteria 6</td>
<td><p>Non-Preferred ACH/LABA: Bevespi Aerosphere, Duaklir Pressair</p>
<p>Preferred Agents: Anoro Ellipta, Stiolto</p></td>
</tr>
<tr class="even">
<td>Criteria 7</td>
<td>Non-Preferred ACH/ICS/LABA: Breztri Aerosphere, Trelegy Ellipta</td>
</tr>
<tr class="odd">
<td>Criteria 8</td>
<td>Albuterol Nebulizer Sol 0.021% (0.63mg/3mL), 0.042% (1.25mg/3mL)- P, AR</td>
</tr>
<tr class="even">
<td>Criteria 9</td>
<td>Budesonide Nebulizer Sol – P, AR</td>
</tr>
</tbody>
</table>

  

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents </th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Glucocorticoids</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ALVESCO</td>
<td>058671</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ALVESCO</td>
<td>058672</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARMONAIR DIGIHALER, RESPICLICK</td>
<td>081476</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARMONAIR DIGIHALER, RESPICLICK</td>
<td>081478</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARMONAIR DIGIHALER, RESPICLICK</td>
<td>081485</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARNUITY ELLIPTA</td>
<td>072722</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARNUITY ELLIPTA</td>
<td>072723</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARNUITY ELLIPTA</td>
<td>078449</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ASMANEX HFA</td>
<td>073197</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ASMANEX HFA</td>
<td>073198</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ASMANEX HFA</td>
<td>080669</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>QVAR</td>
<td>077643</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>QVAR</td>
<td>077644</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLOVENT</td>
<td>019317</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLOVENT</td>
<td>019318</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLOVENT</td>
<td>019319</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLOVENT</td>
<td>021251</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLOVENT</td>
<td>021253</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLOVENT</td>
<td>021483</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0995</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0996</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0996</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>0997</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient 12 years of age or younger?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0998</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0998</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient disabled and unable to use a preferred inhaler?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0999</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0999</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient been non-compliant on a preferred inhaler due to taste, dry mouth, or infection?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1000</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1000</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient clinically unstable, as defined by current guidelines in terms of oral steroid use or patient’s current symptomatology?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1001</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>The preferred medications may include: Asmanex Twisthaler, Flovent, Pulmicort Flexhaler</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>1003 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>8</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>1003  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>9</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1005</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>1005</td>
<td></td>
<td>Select  </td>
<td><p>Is the request for generic Fluticasone HFA (generic Flovent HFA)?</p>
<p>  </p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>12</td>
<td>1006</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y  </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235  </td>
</tr>
<tr class="odd">
<td>13</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>14</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>15</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

<table>
<thead>
<tr class="header">
<th> <strong>Last Approved </strong>   </th>
<th>6/2/2023  </th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Other</strong>  </td>
<td>  </td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Criteria Title</strong> </td>
<td>Respiratory Agents: Inhaled Agents</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred SABAs</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>LEVALBUTEROL NEBULIZER SOL</td>
<td>041848</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LEVALBUTEROL NEBULIZER SOL</td>
<td>041849</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>LEVALBUTEROL NEBULIZER SOL</td>
<td>049871</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LEVALBUTEROL NEBULIZER SOL</td>
<td>057879</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PROAIR DIGIHALER, RESPICLICK</td>
<td>073806</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>PROAIR DIGIHALER, RESPICLICK</td>
<td>080260</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XOPENEX HFA</td>
<td>058890</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1000</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>The preferred medications may include:</p>
<p>Inhalers: Albuterol HFA, Proair HFA, Proventil HFA, Ventolin HFA</p>
<p>Nebulizers: Albuterol Nebulizer Soln</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>4</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>3000</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>3001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>6</td>
<td>3001</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>8</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>9</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Non-Preferred ICS with LABAs

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred ICS with LABAs</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>AIRDUO DIGIHALER, RESPICLICK</td>
<td>077072</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>AIRDUO DIGIHALER, RESPICLICK</td>
<td>077073</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>AIRDUO DIGIHALER, RESPICLICK</td>
<td>077074</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>AIRDUO DIGIHALER, RESPICLICK</td>
<td>081399</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>AIRDUO DIGIHALER, RESPICLICK</td>
<td>081400</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>AIRDUO DIGIHALER, RESPICLICK</td>
<td>081401</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BREO ELLIPTA</td>
<td>070972</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BREO ELLIPTA</td>
<td>071815</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUDESONIDE/FORMOTEROL</td>
<td>062725</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUDESONIDE/FORMOTEROL</td>
<td>062726</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLUTICASONE/SALMETEROL</td>
<td>043366</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLUTICASONE/SALMETEROL</td>
<td>043367</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLUTICASONE/SALMETEROL</td>
<td>043368</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLUTICASONE/SALMETEROL</td>
<td>061344</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FLUTICASONE/SALMETEROL</td>
<td>061345</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FLUTICASONE/SALMETEROL</td>
<td>061343</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>WIXELA INHUB</td>
<td>043366</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>WIXELA INHUB</td>
<td>043367</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>WIXELA INHUB</td>
<td>043368</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0995</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0996</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0996</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>0997</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient 12 years of age or younger?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0998</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0998</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient disabled and unable to use a preferred inhaler?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0999</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0999</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient been non-compliant on a preferred inhaler due to taste, dry mouth, or infection?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1000</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1000</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient clinically unstable, as defined by current guidelines in terms of oral steroid use or patient’s current symptomatology?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1001</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1001</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>The preferred medications may include: Advair Diskus, Advair HFA, Dulera, Symbicort</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>1003 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>8</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>1003  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>9</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1005</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>1005</td>
<td></td>
<td>Select  </td>
<td>Is the request for any of the following: generic Budesonide/Formoterol (generic Symbicort), generic Fluticasone/Salmeterol (generic Advair Diskus or Advair HFA), Brand Breo Ellipta, or generic Fluticasone/Vilanterol (generic Breo Ellipta)?</td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>12</td>
<td>1006</td>
<td></td>
<td>Select  </td>
<td>Which product is being requested?</td>
<td>Budesonide/Formoterol (generic Symbicort)</td>
<td>1007</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Fluticasone/Salmeterol Diskus (generic Advair Diskus)</td>
<td>1007  </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Fluticasone/Salmeterol HFA (generic Advair HFA)</td>
<td>1007  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Breo Ellipta</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Fluticasone/Vilanterol (generic Breo Ellipta)</td>
<td>1007</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>1235  </td>
</tr>
<tr class="odd">
<td>13</td>
<td>1007</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td>Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>15</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td><p>END (Pending Manual Review)</p>
<p> </p></td>
<td></td>
</tr>
<tr class="even">
<td>16</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Non-Preferred Anticholinergics

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Anticholinergics</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>LONHALA MAGNAIR</td>
<td>078010</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LONHALA MAGNAIR</td>
<td>078007</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TUDORZA</td>
<td>069855</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>YUPELRI</td>
<td>079272</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1000</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>The preferred medications may include:</p>
<p>Inhalers: Atrovent HFA, Combivent Respimat, Incruse Ellipta, Ipratropium, Spiriva; Nebulizers: Ipratropium/Albuterol Nebulizer Sol</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>4</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>3000</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>3001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>6</td>
<td>3001</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>8</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>9</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Non-Preferred LABAs

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred LABAs</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>BROVANA</td>
<td>061579</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FORMOTEROL FUMARATE NEBULIZER SOL</td>
<td>063016</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1000</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>The preferred medications may include: Serevent Diskus, Striverdi Respimat.</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>4</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>3000</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>3001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>6</td>
<td>3001</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>8</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>9</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Non-Preferred ACH/LABA

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred ACH/LABA</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>BEVESPI AEROSPHERE</td>
<td>075984</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DUAKLIR PRESSAIR</td>
<td>073344</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0999</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1000</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>The preferred medications may include: Anoro Ellipta, Stiolto.</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>4</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>5</td>
<td>3000</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>3001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>6</td>
<td>3001</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>8</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>9</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Non-Preferred ACH/ICS/LABA

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred ACH/ICS/LABA</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>BREZTRI AEROSPHERE</td>
<td>081351</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRELEGY ELLIPTA</td>
<td>077780</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRELEGY ELLIPTA</td>
<td>081555</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0995</td>
<td></td>
<td>Select </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?  </p>
<p>  </p></td>
<td>New Start (initial authorization request)</td>
<td>0996</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0996</td>
<td> </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>0997</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0997</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient 12 years of age or younger?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0998</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0998</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient disabled and unable to use a preferred inhaler?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0999</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0999</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient been non-compliant on a preferred inhaler due to taste, dry mouth, or infection?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1000</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1000</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the patient clinically unstable, as defined by current guidelines in terms of oral steroid use or patient’s current symptomatology?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1001</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1001</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">two preferred</span> drugs within the same class and duration of action?   </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1002</td>
</tr>
<tr class="odd">
<td>8</td>
<td><p>1002</p>
<p> </p></td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>9</td>
<td>3000</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>3001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>10</td>
<td>3001</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</p>
<p>    </p></td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>12</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>13</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Albuterol Nebulizer Sol

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Albuterol Nebulizer Sol</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ALBUTEROL NEBULIZER SOL 0.021% (0.63 mg/3 mL), 0.042%(1.25 mg/3mL)</td>
<td>048698</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ALBUTEROL NEBULIZER SOL 0.021% (0.63 mg/3 mL), 0.042%(1.25 mg/3mL)</td>
<td>048699</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>1234</td>
<td></td>
<td>Select</td>
<td><p>Is the patient 13 years of age and older?</p>
<p>Please note: a PA is only required for patients 13 years of age and older.</p></td>
<td>Y</td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>3</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>A PA is not required for those younger than 13 years of age.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |

## Budesonide Nebulizer Sol

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Respiratory Agents: Inhaled Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Budesonide Nebulizer Sol</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>BUDESONIDE NEBULIZER SOL</td>
<td>018165</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUDESONIDE NEBULIZER SOL</td>
<td>046525</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUDESONIDE NEBULIZER SOL</td>
<td>046526</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>1234</td>
<td></td>
<td>Select</td>
<td><p>Is the patient 7 years of age and older?</p>
<p>Please note: a PA is only required for patients 7 years of age and older.</p></td>
<td>Y</td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>3</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>A PA is not required for those younger than 7 years of age.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

|||
| ------------------ | -------- |
| **Last Approved ** | 6/2/2023 |
| **Other**          |          |
